Celebrex and regulatory issues

Pfizer's Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painers ibuprofen and naproxen, and does not appear to cause heart problems that spurred the withdrawal of rival Vioxx, according to a large 10-year study presented on Sunday. Regulatory Reconnaissance is our daily intellence briefing for the regulatory affairs space, bringing you the top regulatory news stories from around the globe.
Read more «Celebrex and regulatory issues»

Buy viagra s diary